Mr Mrs Miss Ms Dr Other

Dr
Marta
Kanabus

Senior European Patent Attorney

York Office Manchester Office

Life sciences

Telephone. +44(0) 161 247 4900
Email. [email protected]
Vcard
Linkedin

Experience

Marta's practice focuses on drafting patent applications, as well as overseeing patent application prosecution mainly in Europe, UK and US. She works with a wide variety of clients from all over the world, from universities, research institutes and spin-outs to multinational biotech companies. Marta has particular experience handling portfolios relating to biological therapeutics, personalised medicine, diagnostics and biomarkers.

Prior to joining the profession, Marta obtained a PhD in Biochemistry from University College London. Her doctoral research was aimed at developing new treatments for mitochondrial diseases, as well as finding new genes underlying metabolic disorders and understanding disease mechanisms.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Europe

BSC

Biomedical Science

MSCI

Human Genetics

PHD

Biochemistry

Conferences: 2023

November 21st 2023

LSPN Europe 2023

Attended

Event details

Related News

Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Basics of trade mark protection - National and European perspectives

HGF is pleased to invite you to our upcoming German speaking seminar on “Fundamentals of trade mark protection: National and European Perspectives” in Salzburg and Dresden. The seminar will cover …

Event details

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us